Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-161350
Filing Date
2023-06-06
Accepted
2023-06-06 10:33:57
Documents
2
Period of Report
2023-07-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A d425849ddef14a.htm DEF 14A 456513
2 GRAPHIC g425849g80a01.jpg GRAPHIC 42695
  Complete submission text file 0001193125-23-161350.txt   510272
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-56075 | Film No.: 23995160
SIC: 2833 Medicinal Chemicals & Botanical Products